Gene:
ADH1B
alcohol dehydrogenase 1B (class I), beta polypeptide

PharmGKB contains no prescribing info for this . Contact us to report known genotype-based dosing guidelines, or if you are interested in developing guidelines.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page on the appropriate tab.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

List of all variant annotations for ADH1B

Variant?
(147)
Alternate Names ? Chemicals ? Alleles ?
(+ chr strand)
Function ? Amino Acid?
Translation
rs1229984 NC_000004.11:g.100239319T=, NC_000004.11:g.100239319T>C, NC_000004.12:g.99318162T=, NC_000004.12:g.99318162T>C, NG_011435.1:g.8254A=, NG_011435.1:g.8254A>G, NM_000668.5:c.143A=, NM_000668.5:c.143A>G, NM_001286650.1:c.23A=, NM_001286650.1:c.23A>G, NP_000659.2:p.His48=, NP_000659.2:p.His48Arg, NP_001273579.1:p.His8=, NP_001273579.1:p.His8Arg, XM_005262730.1:c.23A=, XM_005262730.1:c.23A>G, XP_005262787.1:p.His8=, XP_005262787.1:p.His8Arg, rs11537716, rs17028836, rs17856968, rs1789884, rs52797169, rs57624638
T > C
SNP
H48R
No VIP available No Clinical Annotations available VA
rs1229985 NC_000004.11:g.100232878A>G, NC_000004.12:g.99311721A>G, NG_011435.1:g.14695T>C, NM_000668.5:c.829-65T>C, NM_001286650.1:c.709-65T>C, XM_005262730.1:c.709-65T>C, rs1789881
A > G
SNP
No VIP available No Clinical Annotations available VA
rs17033 NC_000004.11:g.100228945T>C, NC_000004.12:g.99307788T>C, NG_011435.1:g.18628A>G, NM_000668.5:c.*52A>G, NM_001286650.1:c.*52A>G, XM_005262730.1:c.*52A>G, rs3805326, rs60655048
T > C
SNP
No VIP available No Clinical Annotations available VA
rs1789891 NC_000004.11:g.100250419C>A, NC_000004.12:g.99329262C>A, rs58189473
C > A
SNP
No VIP available No Clinical Annotations available VA
rs2018417 NC_000004.11:g.100235140C>A, NC_000004.12:g.99313983C>A, NG_011435.1:g.12433G>T, NM_000668.5:c.666G>T, NM_001286650.1:c.546G>T, NP_000659.2:p.Ala222=, NP_001273579.1:p.Ala182=, XM_005262730.1:c.546G>T, XP_005262787.1:p.Ala182=, rs17853136, rs60364763
C > A
SNP
A222A
VIP No Clinical Annotations available No Variant Annotations available
rs2066702 NC_000004.11:g.100229017G>A, NC_000004.12:g.99307860G>A, NG_011435.1:g.18556C>T, NM_000668.5:c.1108C>T, NM_001286650.1:c.988C>T, NP_000659.2:p.Arg370Cys, NP_001273579.1:p.Arg330Cys, XM_005262730.1:c.988C>T, XP_005262787.1:p.Arg330Cys, rs55868078, rs60479679
G > A
SNP
R370C
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP 147

Overview

Alternate Names:  ADH2
Alternate Symbols:  None
PharmGKB Accession Id: PA24571

Details

Cytogenetic Location: chr4 : q23 - q23
GP mRNA Boundary: chr4 : 100227527 - 100242572
GP Gene Boundary: chr4 : 100224527 - 100252572
Strand: minus

Visualization

UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.

View on UCSC Browser
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

ADH1B, also commonly known as ADH2 or ADH beta, is a Class I alcohol dehydrogenase gene. Alcohol dehydrogenases metabolize ethanol to acetaldehyde, which is subsequently metabolized by aldehyde dehydrogenases (ALDH1A, ALDH2 genes) to acetate. This metabolism occurs primarily in the liver [Article:14693654]. The Class I alcohol dehydrogenase family is comprised of ADH1A, ADH1B and ADH1C. Collectively, the Class I ADHs are responsible for the metabolism of about 70% of ethanol in the liver at a concentration of approximately 22mM [Article:16571603]. The Class I ADHs are very similar genes; each is approximately 15 kb in size, and the resulting proteins share a 93% amino acid sequence identity [Article:11274460]. All three Class I genes are clustered on chromosome 4, specifically in the region 4q22 [Article:15099407 16571603]. This class of ADHs is inhibited by pyrazole and its derivatives [Article:15099407].

ADH1B is expressed predominantly in the liver [Article:16792560]. The Km and Vmax values for ethanol as a substrate for ADH1B vary widely depending on the allele of ADH1B, with the *1 allele displaying the lowest Km and Vmax [Article:15099407]. The ADH1B*1 protein structure has been elucidated by x-ray crystallography, and a binding site has been localized near the zinc atom. The ADH1B*1 binding site is predicted to be more restrictive than either ADH1A or ADH1C*2 [Article:11274460]. In vivo, ADH1B exists as a dimer [Article:10441588]. It can either form homodimers or heterodimers with other class 1 ADHs [Article:15099407].

ADH1B*2 and ADH1C*1 are responsible for a more rapid metabolism of alcohol than the other ADH1B and ADH1C alleles. There are conflicting studies as to whether these alleles are in linkage disequilibrium [Article:10441588]. A study of three different Taiwanese populations found the genes to be in linkage disequilibrium [Article:10090900], and LD has also been found in several Caucasian populations [Article:14693654]. However, in other studies, the effect of ADH1C*1 is independent of the ADH1B*2 allele. One study analyzing the drinking habits of Japanese men found this to be the case [Article:17285601]. Another study focusing on a population from Trinidad and Tobago also found independence between ADH1B and ADH1C [Article:17134660].

ADH1B has been studied with conflicting results in association with Fetal Alcohol Syndrome, oral cancer, esophageal cancer, colorectal cancer, testicular atrophy and breast cancer [Article:15099407]. ADH1B genotype has been linked to esophageal cancer along with ALDH2 [Article:17036331]. In another study, ADH1B genotype did not correlate with the risk of laryngeal cancer in a population of Caucasian Germans [Article:12668919]. In yet another study, no correlation was found between ADH1B or ADH1C genotype and alcoholism or liver disease in a Spanish male population [Article:15519646].

ADH1B has been thought to be secondary in importance to ALDH2 in the metabolic conversion of ethanol to acetate. However, at least two studies suggest that protection from alcoholism may affected by ADH1B independently of ALDH2 [Article:10441588 16086315].

The ADH1B*1 allele has been shown to correlate with increased risk of colorectal cancer in one study [Article:17517051]. It has also been associated with increased risk of squamous cell cancer of the head and neck (SCCHN) [Article:17489985]. In one study, the ADH1B*1 allele correlated with the risk of cerebral infarction in Japanese men [Article:15534263]. This allele is more common in alcoholics and in heavy drinkers than in moderate drinkers [Article:15099407]. It is the most prevalent allele in Caucasians, although ADH1B*2 is also found in that population. It is rarely found in Asian populations.

Citation
M. Whirl-Carrillo, E.M. McDonagh, J. M. Hebert, L. Gong, K. Sangkuhl, C.F. Thorn, R.B. Altman and T.E. Klein. "Pharmacogenomics Knowledge for Personalized Medicine" Clinical Pharmacology & Therapeutics (2012) 92(4): 414-417. Full text
History

Submitted by Michelle Whirl Carrillo

Key Publications
  1. Association of alcohol dehydrogenase genes with alcohol dependence: a comprehensive analysis. Human molecular genetics. 2006. Edenberg Howard J, Xuei Xiaoling, Chen Hui-Ju, Tian Huijun, Wetherill Leah Flury, Dick Danielle M, Almasy Laura, Bierut Laura, Bucholz Kathleen K, Goate Alison, Hesselbrock Victor, Kuperman Samuel, Nurnberger John, Porjesz Bernice, Rice John, Schuckit Marc, Tischfield Jay, Begleiter Henri, Foroud Tatiana. PubMed
  2. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. The Proceedings of the Nutrition Society. 2004. Crabb David W, Matsumoto Michinaga, Chang David, You Min. PubMed
  3. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. American journal of epidemiology. 2004. Brennan Paul, Lewis Sarah, Hashibe Mia, Bell Douglas A, Boffetta Paolo, Bouchardy Christine, Caporaso Neil, Chen Chu, Coutelle Christiane, Diehl Scott R, Hayes Richard B, Olshan Andrew F, Schwartz Stephen M, Sturgis Erich M, Wei Qingyi, Zavras Athanasios I, Benhamou Simone. PubMed
Variant Summaries rs1229984, rs2066702
Drugs
Drug (1)
Diseases

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Abacavir Pathway, Pharmacokinetics/Pharmacodynamics
    Schematic representation of abacavir metabolism and mechanism of action. The potential mechanism of an abacavir hypersensitivity reaction is also shown.
  1. Celecoxib Pathway, Pharmacokinetics
    Schematic representation of celecoxib metabolism in human liver cell.
  1. Cyclophosphamide Pathway, Pharmacodynamics
    Model non-tissue-specific cancer cell displaying genes which may be involved in the cyclophosphamide pathway.
  1. Ifosfamide Pathway, Pharmacodynamics
    Model non-tissue specific cancer cell displaying genes which may be involved in the ifosfamide pathway.
No related genes are available

Curated Information ?

Evidence Drug
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available PW
abacavir
ethanol

Curated Information ?

Evidence Disease
Alcoholism

Publications related to ADH1B: 25

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China. Environmental toxicology and pharmacology. 2016. Ding Yipeng, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Ethanol-metabolizing activities and isozyme protein contents of alcohol and aldehyde dehydrogenases in human liver: phenotypic traits of the ADH1B*2 and ALDH2*2 variant gene alleles. Pharmacogenetics and genomics. 2016. Chiang Chien-Ping, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China. International journal of clinical and experimental pathology. 2015. He Yongjun, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Dissecting ancestry genomic background in substance dependence genome-wide association studies. Pharmacogenomics. 2015. Polimanti Renato, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Population pharmacokinetics and pharmacogenetics of alcohol in Chinese and Indians in Singapore. Journal of clinical pharmacy and therapeutics. 2013. Seng K Y, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addiction biology. 2011. Frank Josef, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Breaking Barriers in the Genomics and Pharmacogenetics of Drug Addiction. Clinical pharmacology and therapeutics. 2010. Ho M K, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. Human molecular genetics. 2009. Birley Andrew J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes. The pharmacogenomics journal. 2008. Tolstrup Janne Schurmann, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacology & therapeutics. 2008. Hines Ronald N. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcoholism, clinical and experimental research. 2007. Visvanathan Kala, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A common coding variant in CASP8 is associated with breast cancer risk. Nature genetics. 2007. Cox Angela, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. Human molecular genetics. 2007. Luo Xingguang, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Health-related effects of genetic variations of alcohol-metabolizing enzymes in African Americans. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism. 2007. Scott Denise M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Variations in ADH and ALDH in Southwest California Indians. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism. 2007. Ehlers Cindy L. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. American journal of human genetics. 2006. Luo Xingguang, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Association of alcohol dehydrogenase genes with alcohol dependence: a comprehensive analysis. Human molecular genetics. 2006. Edenberg Howard J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Functionality of allelic variations in human alcohol dehydrogenase gene family: assessment of a functional window for protection against alcoholism. Pharmacogenetics. 2004. Lee Shou-Lun, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. The Proceedings of the Nutrition Society. 2004. Crabb David W, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. American journal of epidemiology. 2004. Brennan Paul, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Protective association of genetic variation in alcohol dehydrogenase with alcohol dependence in Native American Mission Indians. The American journal of psychiatry. 2003. Wall Tamara L, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Influence of ADH1B polymorphism on alcohol use and its subjective effects in a Jewish population. American journal of medical genetics. 2002. Carr Lucinda G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. American journal of human genetics. 1999. Chen C C, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ADH genotypes and alcohol use and dependence in Europeans. Alcoholism, clinical and experimental research. 1998. Whitfield J B, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcoholism, clinical and experimental research. 1997. Tanaka F, et al. PubMed

LinkOuts

NCBI Gene:
125
OMIM:
103720
103780
UCSC Genome Browser:
NM_000668
RefSeq RNA:
NM_000668
RefSeq Protein:
NP_000659
RefSeq DNA:
NG_011435
NT_016354
UniProtKB:
ADH1B_HUMAN (P00325)
Ensembl:
ENSG00000196616
GenAtlas:
ADH1B
GeneCard:
ADH1B
MutDB:
ADH1B
ALFRED:
LO000002C
HuGE:
ADH1B
Comparative Toxicogenomics Database:
125
ModBase:
P00325
HumanCyc Gene:
HS08983
HGNC:
250

Common Searches